Literature DB >> 19644645

Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failure.

Tommaso Gori1, Thomas Münzel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19644645     DOI： 10.1007/s00392-009-0053-x

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  9 in total

1.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

2.  Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure.

Authors:  Andreas Daiber; Matthias Oelze; Meike Coldewey; K Kaiser; C Huth; S Schildknecht; M Bachschmid; Y Nazirisadeh; V Ullrich; A Mülsch; T Münzel; N Tsilimingas
Journal:  Biochem Biophys Res Commun       Date:  2005-11-11       Impact factor: 3.575

3.  Survey of the use of organic nitrates for the treatment of chronic congestive heart failure in the United States.

Authors:  Fahed Bitar; Mohammed W Akhter; Salman Khan; Harpreet Singh; Uri Elkayam
Journal:  Am J Cardiol       Date:  2004-12-01       Impact factor: 2.778

Review 4.  Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.

Authors:  Uri Elkayam; Fahed Bitar
Journal:  Am J Cardiol       Date:  2005-08-09       Impact factor: 2.778

Review 5.  Non-hemodynamic effects of organic nitrates and the distinctive characteristics of pentaerithrityl tetranitrate.

Authors:  Tommaso Gori; Andreas Daiber
Journal:  Am J Cardiovasc Drugs       Date:  2009       Impact factor: 3.571

Review 6.  Nitrate-induced toxicity and preconditioning: a rationale for reconsidering the use of these drugs.

Authors:  Tommaso Gori; John D Parker
Journal:  J Am Coll Cardiol       Date:  2008-07-22       Impact factor: 24.094

7.  Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure.

Authors:  Wilfried Mullens; Zuheir Abrahams; Gary S Francis; George Sokos; Randall C Starling; James B Young; David O Taylor; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2009-02-21       Impact factor: 2.778

Review 8.  New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance.

Authors:  A Daiber; P Wenzel; M Oelze; T Münzel
Journal:  Clin Res Cardiol       Date:  2007-10-19       Impact factor: 5.460

9.  Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.

Authors:  Jay N Cohn; S William Tam; Inder S Anand; Anne L Taylor; Michael L Sabolinski; Manuel Worcel
Journal:  J Card Fail       Date:  2007-06       Impact factor: 5.712
  9 in total
  1 in total

1.  Chronic protection against ischemia and reperfusion-induced endothelial dysfunction during therapy with different organic nitrates.

Authors:  Monica Lisi; Matthias Oelze; Saverio Dragoni; Andrew Liuni; Sebastian Steven; Mary-Clare Luca; Dirk Stalleicken; Thomas Münzel; Franco Laghi-Pasini; Andreas Daiber; John D Parker; Tommaso Gori
Journal:  Clin Res Cardiol       Date:  2012-06       Impact factor: 5.460
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.